Immunospot assay based on fluorescent nanoparticles for Dengue fever detection

Area of Science:

• Tropical Medicine
• Biotechnology
• Immunodiagnostics

Background:

• Dengue fever is a major global health concern, causing millions of infections annually.
• Early detection of Dengue NS1 antigen is crucial for reducing mortality rates.
• Current ELISA methods for NS1 detection are time-consuming, hindering rapid diagnosis during epidemics.

Purpose of the Study:

• To develop a rapid, sensitive, and specific diagnostic method for Dengue NS1 antigen.
• To overcome the limitations of existing time-consuming diagnostic assays.
• To provide a suitable method for Dengue NS1 detection in resource-limited settings.

Main Methods:

• A novel assay combining fluorophore-linked immunosorbent assay (FLISA) and enzyme-linked immunospotting (ELISPOT) principles was developed.
• Detection utilized mouse anti-NS1 IgG labeled with fluorescent nanoparticles.
• The assay requires minimal sample volume (4 μL) and has a short turnaround time (45-60 min).

Main Results:

• The new method achieved a detection limit of 5.2 ng/mL, comparable to ELISA.
• Evaluation with 83 samples showed 81% sensitivity and 88% specificity against a commercial ELISA.
• Fluorescent nanoparticles enhanced sensitivity and avoided photobleaching issues common with standard fluorescent dyes.

Conclusions:

• The developed FLISA/ELISPOT method offers a fast, specific, and sensitive approach for Dengue NS1 detection.
• This assay is well-suited for Dengue diagnosis in epidemic-stricken or impoverished regions.
• The rapid nature of this test can significantly improve patient outcomes by enabling prompt treatment.